Influenza vaccination in the elderly: Effectiveness not in doubt;Griepvaccinatie bij ouderen: Geen twijfel aan de effectiviteit

Nederlands Tijdschrift voor Geneeskunde

Volumn 152, Issue 19, 2008, Pages 1081-1083

  Hak, E ^a   Opstelten, W ^b   Looijmans van Den Akker, I ^a   Knottnerus, J A ^c  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b DUTCH COLLEGE OF GENERAL PRACTITIONERS   (Netherlands)

^c Gezondheidsraad   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

DRUG EFFECT; GERIATRIC CARE; HUMAN; INFECTION RISK; INFLUENZA; INFLUENZA VACCINATION; MORBIDITY; MORTALITY; NOTE; TREATMENT OUTCOME;

AGED; AGING; CAUSE OF DEATH; FEMALE; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; SELECTION BIAS;

EID: 44949225178     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (11)

1. Simonsen L, Taylor RJ, Viboud C, Miller MA, Jackson LA. Mortality benefits of influenza vaccination in elderly people: an ongoing controversy. Lancet Infect Dis. 2007;7:658-66.
2. Commissie griepvaccinatie: herziening van de indicatiestelling. Griepvaccinatie: herziening van de indicatiestelling. Publicatienr 2007/09. Den Haag: Gezondheidsraad; 2007.
3. Hak E, Hoes AW, Nordin J, Nichol KL. Benefits of influenza vaccine in US elderly - appreciating issues of confounding bias and precision [letter]. Int J Epidemiol. 2006;35:800-2.
4. Govaert TM, Thijs CT, Masurel N, Sprenger MJ, Dinant GJ, Knottnerus JA. The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial. JAMA. 1994;272:1661-5.
5. Jefferson T, Rivetti D, Rivetti A, Rudin M, di Pietrantoni C, Demicheli V. Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review. Lancet. 2005;366:1165-74.
6. Hak E, Buskens E, Essen GA van, Bakker DH de, Grobbee DE, Tacken MA, et al. Clinical effectiveness of influenza vaccination in persons younger than 65 years with high-risk medical conditions: the PRISMA study. Arch Intern Med. 2005;165:274-80.
7. Voordouw AC, Sturkenboom MC, Dieleman JP, Stijnen T, Smith DJ, Lei J van der, et al. Annual revaccination against influenza and mortality risk in community-dwelling elderly persons. JAMA. 2004;292:2089-95.
8. Nichol KL, Nordin JD, Nelson DB, Mullooly JP, Hak E. Effectiveness of influenza vaccine in the community-dwelling elderly. N Engl J Med. 2007;357:1373-81.
9. Nichol KL, Nordin J, Mullooly J, Lask R, Fillbrandt K, Iwane M. Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. N Engl J Med. 2003;348:1322-32.
10. Hak E, Nordin J, Wei F, Mullooly J, Poblete S, Strikas R, et al. Influence of high-risk medical conditions on the effectiveness of influenza vaccination among elderly members of 3 large managed-care organizations. Clin Infect Dis. 2002;35:370-7.
11. Jansen AG, Sanders EA, Hoes AW, Loon AM van, Hak E. Influenza-and respiratory syncytial virus-associated mortality and hospitalisations. Eur Respir J. 2007;30:1158-66.